Orion Affirms FY25 Net Sales, Operating Profit Outlook

Published on 2025-04-23 at 05:41 - Modified on 2025-04-23 at 05:47

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Orion Oyj

Orion Oyj, H1 2025 Earnings Call, Jul 18, 2025	07-18
Orion Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	07-18	CI
Orion Q2 operating profit EUR 104.6 mln	07-18	RE
Orion Reports Stronger-than-Expected Operating Profit (Update)	07-18	FW
Orion Posts Stronger-Than-Expected Operating Profit in Q2	07-18	FW
Orion Oyj - Analyst/Investor Day	07-16
Orion raises outlook for 2025	07-09	RE
Orion Upgrades FY25 Net Sales, Operating Profit Outlook	07-09	MT
Orion Raises Forecasts for 2025	07-09	FW
Orion Oyj Upgrades Earnings Guidance for Full-Year 2025	07-09	CI
Orion Corporation Recommends Third Indication for Darolutamide for Patients with Advanced Prostate Cancer	06-20	CI
Bayer, Orion's Prostate Cancer Treatment Recommended for EU Approval in Third Indication	06-20	MT
CHMP Recommends Third Indication For Darolutamide For Patients With Advanced Prostate Cancer	06-20	RE
Orion Extend Research, Licensing Deal for Antibody-drug Conjugates with Glykos Finland	06-17	MT
Orion, Glykos Announce Extension Of Research Collaboration, Licensing Agreement	06-17	RE
Orion and Glykos Announce the Extension of Their Research Collaboration and Licensing Agreement for the Development of Next-Generation ADCs	06-17	CI
US FDA Approves New Indication for Bayer, Orion's Prostate Cancer Treatment	06-03	MT
U.S. FDA Approves Third Indication of Darolutamide for Patients with Advanced Prostate Cancer	06-03	CI
Orion, Shilpa Medicare Enter Commercial Deal for Albumin Product in Europe	05-23	MT
Orion Signs Agreement With Shilpa Medicare	05-23	RE
Orion Corporation Announces Agreement with Shilpa Medicare for Recombinant Human Albumin for European Market	05-23	CI
Aktiespararna is adding Orion and Storytel to its small-cap portfolio.	05-08	FW
Orion to License Criceto's Parkinson's Rescue Spray	04-25	MT
Orion And Criceto Announce License Agreement For Aporon	04-25	RE
Carnegie Group Upgrades Orion to Buy, Lifts PT	04-24	MT